Debanjan Ray - Chief Financial Officer, Cytomx Therapeutics, Inc

As of January 29, 2019


What is Debanjan Ray's Net Worth?

The current estimated net worth of Cytomx Therapeutics, Inc's Chief Financial Officer, Debanjan Ray, is estimated to be about $1.99M . Debanjan Ray owns about 5,928 units of Cytomx Therapeutics, Inc common stock. In the last 2 years at Cytomx Therapeutics, Inc, Debanjan Ray has sold an estimated value of $1.98M worth.

What is Debanjan Ray's Past Insider Trading?

Debanjan Ray's largest purchase order was 33,000 units , worth over $39.75K on March 5, 2018. Debanjan Ray's largest sale order was 33,000 units , worth over $989.69K on March 5, 2018. In total, Debanjan Ray has made about 21 transactions over 2 years of their time at Cytomx Therapeutics, Inc. Debanjan Ray usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 3,000 units , worth over $45K on December 14, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Debanjan Ray's' Mailing Address?

  • Mailing address is C/o Cytomx Therapeutics, Inc. 151 Oyster Point Blvd, Suite 400 South San Francisco CA 94080 CA

What are Cytomx Therapeutics, Inc's Past Insider Trades?

Cytomx Therapeutics, Inc's most recent insider trade came on June 21, 2021 by Sean A McCarthy who sold 100,000 units worth $704.47K . In the last 6 years, insiders at Cytomx Therapeutics, Inc have sold an estimated value of $57.52M and bought an estimated value of $10.27M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Sean A McCarthy, President and CEO,  Debanjan Ray, Chief Financial Officer,  and Canaan Ix Lp, Director .

CytomX Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1